317 related articles for article (PubMed ID: 34295880)
1. Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn's Disease.
He C; Wang H; Yu C; Peng C; Shu X; Liao W; Zhu Z
Front Bioeng Biotechnol; 2021; 9():673691. PubMed ID: 34295880
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
[TBL] [Abstract][Full Text] [Related]
4. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
5. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
[TBL] [Abstract][Full Text] [Related]
6. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
7. Deciphering salivary microbiome signature in Crohn's disease patients with different factors contributing to dysbiosis.
Elzayat H; Malik T; Al-Awadhi H; Taha M; Elghazali G; Al-Marzooq F
Sci Rep; 2023 Nov; 13(1):19198. PubMed ID: 37932491
[TBL] [Abstract][Full Text] [Related]
8. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
[TBL] [Abstract][Full Text] [Related]
9. Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients.
Alatawi H; Mosli M; Saadah OI; Annese V; Al-Hindi R; Alatawy M; Al-Amrah H; Alshehri D; Bahieldin A; Edris S
Bosn J Basic Med Sci; 2022 Jun; 22(3):412-426. PubMed ID: 34761733
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
[TBL] [Abstract][Full Text] [Related]
11. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
12. Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome.
Jacobs JP; Goudarzi M; Lagishetty V; Li D; Mak T; Tong M; Ruegger P; Haritunians T; Landers C; Fleshner P; Vasiliauskas E; Ippoliti A; Melmed G; Shih D; Targan S; Borneman J; Fornace AJ; McGovern DPB; Braun J
Genome Med; 2022 Aug; 14(1):91. PubMed ID: 35971134
[TBL] [Abstract][Full Text] [Related]
13. Characterization of fungal and bacterial dysbiosis in young adult Chinese patients with Crohn's disease.
Qiu X; Zhao X; Cui X; Mao X; Tang N; Jiao C; Wang D; Zhang Y; Ye Z; Zhang H
Therap Adv Gastroenterol; 2020; 13():1756284820971202. PubMed ID: 33240394
[TBL] [Abstract][Full Text] [Related]
14. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment.
Yoon H; Park YS; Shin CM; Kim N; Lee DH
Yonsei Med J; 2022 Jan; 63(1):34-41. PubMed ID: 34913282
[TBL] [Abstract][Full Text] [Related]
16. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
[TBL] [Abstract][Full Text] [Related]
17. A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.
Zhang Z; Taylor L; Shommu N; Ghosh S; Reimer R; Panaccione R; Kaur S; Hyun JE; Cai C; Deehan EC; Hotte N; Madsen KL; Raman M
J Crohns Colitis; 2020 Nov; 14(11):1547-1557. PubMed ID: 32343765
[TBL] [Abstract][Full Text] [Related]
18. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota analysis for prediction of clinical relapse in Crohn's disease.
Buffet-Bataillon S; Bouguen G; Fleury F; Cattoir V; Le Cunff Y
Sci Rep; 2022 Nov; 12(1):19929. PubMed ID: 36402792
[TBL] [Abstract][Full Text] [Related]
20. Microbial Signature in Adipose Tissue of Crohn's Disease Patients.
Serena C; Queipo-Ortuño M; Millan M; Sanchez-Alcoholado L; Caro A; Espina B; Menacho M; Bautista M; Monfort-Ferré D; Terrón-Puig M; Núñez-Roa C; Maymó-Masip E; Rodriguez MM; Tinahones FJ; Espin E; Martí M; Fernández-Veledo S; Vendrell J
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
